← brief for 2026-10-16 · Slowing decline

Eculizumab in rapidly progressive glomerulonephritis: a case-series report

Article No results yet Peer reviewed

Key takeaways

This is a small group of patients using a specific drug for fast kidney damage. It is not a large study, and we do not have the results yet.

Who did this work

Li X (Department of Nephrology, The Second Affiliated Hospital of Nanchang University , , , ) · Zhang Y (Department of Nephrology, The Second Affiliated Hospital of Nanchang University , , , ) · Ke B (Department of Nephrology, The Second Affiliated Hospital of Nanchang University , , , )

Source

Article · Europe PMC, CKD · 2026-10-16
https://europepmc.org/article/PMC/PMC13655034